These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35105682)

  • 21. Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil.
    Sartori AMC; de Soárez PC; Fernandes EG; Gryninger LCF; Viscondi JYK; Novaes HMD
    Vaccine; 2016 Mar; 34(13):1531-1539. PubMed ID: 26899375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disparities in Tdap Vaccination and Vaccine Information Needs Among Pregnant Women in the United States.
    Kriss JL; Albert AP; Carter VM; Jiles AJ; Liang JL; Mullen J; Rodriguez L; Howards PP; Orenstein WA; Omer SB; Fisher A
    Matern Child Health J; 2019 Feb; 23(2):201-211. PubMed ID: 30288661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antenatal influenza and pertussis vaccination in Western Australia: a cross-sectional survey of vaccine uptake and influencing factors.
    Mak DB; Regan AK; Vo DT; Effler PV
    BMC Pregnancy Childbirth; 2018 Oct; 18(1):416. PubMed ID: 30355329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A quality improvement initiative to increase Tdap (tetanus, diphtheria, acellular pertussis) vaccination coverage among direct health care providers at a children's hospital.
    Jiang C; Whitmore-Sisco L; Gaur AH; Adderson EE;
    Vaccine; 2018 Jan; 36(2):214-219. PubMed ID: 29217370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand.
    Koepke R; Eickhoff JC; Ayele RA; Petit AB; Schauer SL; Hopfensperger DJ; Conway JH; Davis JP
    J Infect Dis; 2014 Sep; 210(6):942-53. PubMed ID: 24903664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with Tdap vaccination receipt during pregnancy: a cross-sectional study.
    Wales DP; Khan S; Suresh D; Ata A; Morris B
    Public Health; 2020 Feb; 179():38-44. PubMed ID: 31726399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tdap vaccination during pregnancy to protect newborns from pertussis infection.
    Mazzilli S; Tavoschi L; Lopalco PL
    Ann Ig; 2018; 30(4):346-363. PubMed ID: 29895052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient attitudes toward influenza and tetanus, diphtheria and acellular pertussis vaccination in pregnancy.
    Strassberg ER; Power M; Schulkin J; Stark LM; Mackeen AD; Murtough KL; Paglia MJ
    Vaccine; 2018 Jul; 36(30):4548-4554. PubMed ID: 29907484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of a Best-Practice Alert and Prenatal Administration With Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination Rates.
    Morgan JL; Baggari SR; Chung W; Ritch J; McIntire DD; Sheffield JS
    Obstet Gynecol; 2015 Aug; 126(2):333-337. PubMed ID: 26241423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tdap vaccination coverage during pregnancy, active component service women, 2006-2014.
    Eick-Cost AA; Hu Z
    MSMR; 2015 May; 22(5):11-4. PubMed ID: 25996172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obstetric and perinatal health outcomes after pertussis vaccination during pregnancy in Ontario, Canada: a retrospective cohort study.
    Fakhraei R; Crowcroft N; Bolotin S; Sucha E; Hawken S; Wilson K; Gaudet L; Amirthalingam G; Biringer A; Cook J; Dubey V; Halperin SA; Jamieson F; Kwong JC; Sadarangani M; Walker MC; Laverty M; Fell DB
    CMAJ Open; 2021; 9(2):E349. PubMed ID: 33849984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vital Signs: Burden and Prevention of Influenza and Pertussis Among Pregnant Women and Infants - United States.
    Lindley MC; Kahn KE; Bardenheier BH; D'Angelo DV; Dawood FS; Fink RV; Havers F; Skoff TH
    MMWR Morb Mortal Wkly Rep; 2019 Oct; 68(40):885-892. PubMed ID: 31600186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies.
    Abu-Raya B; Giles ML; Kollmann TR; Sadarangani M
    Front Immunol; 2019; 10():2423. PubMed ID: 31681310
    [No Abstract]   [Full Text] [Related]  

  • 34. Effectiveness of Prenatal Tetanus, Diphtheria, and Acellular Pertussis Vaccination on Pertussis Severity in Infants.
    Winter K; Cherry JD; Harriman K
    Clin Infect Dis; 2017 Jan; 64(1):9-14. PubMed ID: 27624956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantity and Quality of Antibodies After Acellular Versus Whole-cell Pertussis Vaccines in Infants Born to Mothers Who Received Tetanus, Diphtheria, and Acellular Pertussis Vaccine During Pregnancy: A Randomized Trial.
    Wanlapakorn N; Maertens K; Vongpunsawad S; Puenpa J; Tran TMP; Hens N; Van Damme P; Thiriard A; Raze D; Locht C; Poovorawan Y; Leuridan E
    Clin Infect Dis; 2020 Jun; 71(1):72-80. PubMed ID: 31418814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expected challenges of implementing universal pertussis vaccination during pregnancy in Quebec: a cross-sectional survey.
    Brousseau N; Gagnon D; Vivion M; Poliquin V; Boucoiran I; Tapiéro B; Dubé E
    CMAJ Open; 2018; 6(3):E391-E397. PubMed ID: 30237315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perinatal health care providers' approaches to recommending and providing pertussis vaccination in pregnancy: a qualitative study.
    Mijović H; Greyson D; Gemmell E; Trottier MÈ; Vivion M; Graham JE; Dubé È; Bettinger JA
    CMAJ Open; 2020; 8(2):E377-E382. PubMed ID: 32414884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen®) vaccine for immunization of adolescents and adults in Thailand.
    Fortuna L; Chaithongwongwatthana S; Soonthornworasiri N; Spiegel J; Wijagkanalan W; Mansouri S; van den Biggelaar AHJ; Pham HT
    Vaccine; 2020 Dec; 38(51):8194-8199. PubMed ID: 33176935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine attitudes and practices among obstetric providers in New York State following the recommendation for pertussis vaccination during pregnancy.
    Bonville CA; Cibula DA; Domachowske JB; Suryadevara M
    Hum Vaccin Immunother; 2015; 11(3):713-8. PubMed ID: 25714987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.